New 'Touch' test could spot breast cancer faster than biopsy
NCT ID NCT06085833
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new device called ARTIDIS that measures how stiff or soft breast tissue is, which may help doctors tell if a lump is cancerous. About 2,700 people with suspicious breast lesions will have their biopsy tissue tested with this device. The goal is to see if it can accurately diagnose cancer and predict how aggressive it is, compared to standard lab analysis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ARTIDIS ART-1 device (nanomechanical phenotype test)
What this could lead to
If successful, this could provide a faster, more accurate way to diagnose breast cancer and predict tumor aggressiveness without relying solely on traditional pathology.
What could go wrong
This is an early-stage diagnostic study, not a treatment trial. The device's accuracy may not be high enough to replace current methods, and results may vary across different patient groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Claraspital
RECRUITINGBasel, Basel, CH-4058, Switzerland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Vall d'Hebron
RECRUITINGBarcelona, Barcelona, 08035, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
MD Anderson Cancer Clinic - Mays Clinic
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Texas Southwestern Medical Center
RECRUITINGDallas, Texas, 75390-9020, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••